controversy about Zohydro ER (zoh-HYE-droh), the first single-ingredient, extended-release form of hydrocodone

See updated DEA information concerning the rescheduling of hydrocodone combination products to Schedule II.

You'll hear lots of controversy about Zohydro ER (zoh-HYE-droh), the first single-ingredient, extended-release form of hydrocodone.

Think of it as an alternative to other LONG-acting opioids...OxyContin, MS Contin, Avinza, etc.

Zohydro ER contains 10 to 50 mg/cap of hydrocodone...to be given every 12 hours for severe CHRONIC pain.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote